<DOC>
	<DOC>NCT01061567</DOC>
	<brief_summary>The general aim of this non-interventional study is to assess the safety and efficacy of pramipexole extended release in patients with Parkinson's disease in routine clinical practice.</brief_summary>
	<brief_title>Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Inclusion criteria: Early and advanced idiopathic Parkinson's disease Male and female patients over 18 years of age Indication for treatment with pramipexole ER according to Summary of Product Characteristics (SmPC) Exclusion criteria: Ongoing treatment with pramipexole ER Exclusion criteria in line with the pramipexole ER SmPC: In particular hypersensitivity to pramipexole or to any of the excipients and pregnancy and lactation as stated in the SmPC.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>